TipHub

₹1,330

▼ -0.4 -0.03%

30 Jul 2026

NSE Listed · Pharmaceuticals

Concord Biotech Limited (CONCORDBIO)

Volume: 1,65,417Avg Vol 1W: 1,00,659Avg Vol 1M: 1,02,24152W Range:₹987₹1,880.8
NSE BSE www.concordbiotech.com AI Report
Key Ratios
Checked just now
Market Cap₹13,914 Cr
Current Price₹1,330
Previous Close₹1,330.4
High / Low (52w)₹1,880.8 / ₹987
Volume1,65,417
Avg Vol (1W)1,00,659
Avg Vol (1M)1,02,241
Stock P/E157.21
Book Value₹192.84
Dividend Yield0.56%
ROE12.94%
ROA11.6%
Revenue (TTM)—
Revenue Growth18.01%
Profit Margin24.73%
Total Debt₹0 Cr
Shares Outstanding10 Cr
Face Value₹1
EPS (TTM)₹8.46
P/B6.9
Debt / Equity0
50 DMA₹1,266.43
200 DMA₹1,263.23
Day change-0.03%
Price Chart
₹1,330▼ 27.08% · 1Y
₹1872₹10151.1Cr
2025-07-30
2026-07-30

20-day avg volume: 1.0L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 240% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 157.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹216 Cr₹310 Cr₹244 Cr₹430 Cr₹204 Cr₹247 Cr₹278 Cr₹326 Cr
EBITDA₹78 Cr₹133 Cr₹99 Cr₹185 Cr₹57 Cr₹83 Cr₹90 Cr₹114 Cr
Net Profit₹60 Cr₹96 Cr₹76 Cr₹140 Cr₹44 Cr₹64 Cr₹64 Cr₹89 Cr
EPS————————
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹244 Cr₹430 Cr₹1,245 Cr₹204 Cr₹247 Cr₹278 Cr₹1,107 Cr₹326 Cr
EBITDA₹99 Cr₹185 Cr₹496 Cr₹57 Cr₹86 Cr₹94 Cr₹345 Cr₹118 Cr
Net Profit₹74 Cr₹142 Cr₹372 Cr₹43 Cr₹63 Cr₹68 Cr₹261 Cr₹90 Cr
EPS——35.52———24.78—
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹941 Cr₹1,183 Cr₹1,313 Cr₹1,514 Cr₹1,701 Cr₹2,034 Cr₹2,235 Cr
Total Liabilities₹170 Cr₹183 Cr₹210 Cr₹224 Cr₹174 Cr₹222 Cr₹220 Cr
Equity₹770 Cr₹999 Cr₹1,103 Cr₹1,290 Cr₹1,527 Cr₹1,813 Cr₹2,015 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹204 Cr₹268 Cr₹316 Cr₹369 Cr₹354 Cr₹367 Cr
Investing₹-114 Cr₹-112 Cr₹-158 Cr₹-155 Cr₹-160 Cr₹-143 Cr
Financing₹-43 Cr₹-100 Cr₹-85 Cr₹-99 Cr₹-99 Cr₹-113 Cr
Free Cash Flow₹204 Cr₹268 Cr₹316 Cr₹369 Cr₹354 Cr₹367 Cr
Shareholding
Promoter 44.08% Institutions 16.88% Public 39.03%
Efficiency & Working Capital
ROCE29.6%
Interest Coverage421.3
Dividend Payout—
Debtor Days159 d
Inventory Days113 d
Payable Days35 d
Cash Conversion Cycle237 d
Working Capital Days272 d
Shareholding Details

As of 2026-06-30

Promoter44.1%
FII7.5%
DII9.4%
Institutions16.9%
Public39%
Promoter Pledge0%
No. of Shareholders83,325
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%44.1%
FIIs7.3%7%6.5%7.1%8.1%8.3%9.4%9.1%8%7.6%7.8%7.5%
DIIs8.2%8.1%8.5%10.4%9.9%9.7%9.2%8.9%9.6%9.6%9.2%9.4%
Public40.4%40.8%41%38.4%37.9%37.9%37.4%37.9%38.3%38.8%38.9%39%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,00,92787,48683,29680,73784,29882,00481,21982,04582,65081,81582,24983,325
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sudhir Kumar VaidShareholding of Promoter and Promoter Group28.8%3.02 Cr
Manju VaidShareholding of Promoter and Promoter Group9.6%99,87,636
Aryavir Jhunjhunwala Discretionary TrustPublic Shareholding8%83,99,754
Aryaman Jhunjhunwala Discretionary TrustPublic Shareholding8%83,99,754
Nishtha Jhunjhunwaladiscretionary TrustPublic Shareholding8%83,99,732
Sudman Consultants LlpShareholding of Promoter and Promoter Group4.5%47,52,000
Government Pension Fund GlobalPublic Shareholding3%30,91,239
Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap FundPublic Shareholding2.5%25,90,472
1575773 Ontario IncPublic Shareholding2%20,92,325
Dsp Small Cap FundPublic Shareholding1.8%18,28,753
Axis Max Life Insurance Limited A/c Reversionary Bonus Participating - EquityPublic Shareholding1.3%13,99,464
Ravindra Raichand DharamshiPublic Shareholding1.2%12,56,432
Chanakya Corporate Services Pvt LtdPublic Shareholding1.1%11,63,833
Ohm Stock Broker Private LimitedPublic Shareholding1.1%11,00,000
Ankur Sudhir VaidShareholding of Promoter and Promoter Group0.6%5,86,520
Vaid Megha AnkurShareholding of Promoter and Promoter Group0.5%5,47,008
Sonal KumraShareholding of Promoter and Promoter Group0.1%73,920
Aarav VaidShareholding of Promoter and Promoter Group0%0
Myra VaidShareholding of Promoter and Promoter Group0%0
Gaurav KumraShareholding of Promoter and Promoter Group0%0
Concord Lifegen LimitedShareholding of Promoter and Promoter Group0%0
Clean Max Everglades Private LimitedShareholding of Promoter and Promoter Group0%0
Concord Biotech Japan KkShareholding of Promoter and Promoter Group0%0
Celliimune Biotech Private LimitedShareholding of Promoter and Promoter Group0%0
Stellon Biotech Inc.Shareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
SUDHIR JAIRAM VAIDChairman / Executive Director / M D / Promoter2026
ANKUR VAIDED / Joint MD / CEO / Promoter2026
Ravi KapoorNon-Exec & Non-Independent Dir2026
Rajiv AgarwalNon-Exec & Non-Independent Dir2026
BHARTI KHANNAIndependent Non Exe. Director2026
Amitabh ThakoreIndependent Non Exe. Director2026
Arvind AgarwalIndependent Non Exe. Director2026
Jayaram EaswaranIndependent Non Exe. Director2026
Mandayam Chakravarthy SriramanIndependent Non Exe. Director2026
Paritosh TrivediCompany Sec. & Compli. Officer2026
EKTA GUPTAIndependent Non Exe. Director2026
Segments — Geography
RegionRevenueShare
Within India₹662 Cr55.1%
America₹138 Cr11.5%
Others₹400 Cr33.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1111010
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-31Board Meetings—
forthcoming2026-07-24Dividend (7.55/- per share)Final
dividend2026-07-24₹7.55 (755%)Final
dividend2025-09-03₹10.7 (1070%)Final
forthcoming—Book ClosureAGM & 755% Final Dividend
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202631033495132
202614000014
2026150449588
Insider / Designated-Person Trades

11 recent disclosure(s)

Prakash Lalchand SajnaniDisposal · 5,000
Chandrashekhar Mukundrao ChawanDisposal · 1,000
Devang BhattDisposal · 3,000
Kanishka KapoorDisposal · 10,000
Ravi KapoorDisposal · 10,000
Rajendra ModiDisposal · 4,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market28/05/2024 · 35,48,211
Company Information
Incorporated1984
ChairmanSUDHIR JAIRAM VAID
AuditorBSR & Co LLP
Investor Email[email protected]
🌐 www.concordbiotech.com ↗

📍 1482-86 Trasad Road, Dholka, Ahmedabad, Gujarat, 382225

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Comfort Intech Ltd.Committed Cargo Care Ltd.Compuage Infocom Ltd.Compucom Software Ltd.Commercial Syn Bags Ltd.Container Corporation Of India Ltd.Confidence Petroleum India Ltd.Connplex Cinemas LimitedConsolidated Finvest & Holdings Ltd.Continental Seeds and Chemicals Ltd.Control Print LimitedCool Caps Industries Ltd.All “C” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search